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SocietyIn the November 2006 issue of Osteoarthritis and Cartilage,
Tiderius et al.1 identiﬁed that body mass index (BMI) could
be a source of dosing bias in delayed gadolinium-enhanced
magnetic resonance imaging of cartilage (dGEMRIC) and
a correction factor should be identiﬁed to be applied in
cross-sectional studies of BMI. These investigators suggest
bias corrections when evaluating populations with a wide
range of BMI or in situations where BMI changes over
time. They suggest that corrections are necessary as errors
may be as much as 20% in extreme BMI measures.
The use of BMI to address this bias may be problematic
because gadolinium with diethylenetriamine penta-acetic
acid (Gd-DTPA) ion is distributed in the extracellular water,
and as Tiderius et al. acknowledge, lean tissue has about
twice the extracellular ﬂuid per unit weight as adipose tis-
sue. Indeed, adipose tissue is approximately 15% ﬂuid.
Thus, the use of BMI may result in an inappropriate bias
correction.
Further, we have submitted a manuscript to Osteoarthritis
and Cartilage which indicates that the use of fat and skeletal
muscle mass measures explains more variation in (and are
better correlated with) knee osteoarthritis (OA) measures
than is BMI. Further, the measure of skeletal muscle mass,
rather than fat mass, is strikingly associated with OA.
There are four reasons that corrections should be based
on skeletal muscle mass rather than fat mass or its corre-
late, BMI.
(1) Gadolinium is distributed in the extracellular ﬂuid of
skeletal muscle mass.
(2) The body composition element that is actually best
associated with OA is skeletal muscle mass.
(3) OA is likely to be associated with a very wide range of
body composition and BMI.
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Fax: 1-734-998-8027; E-mail: mfsowers@umich.edu59(4) There are notable changes in fat mass with aging, but
the changes in skeletal muscle mass are less pro-
nounced and less likely to have the transitory changes
associated with fat mass.
Thus, while Tiderius et al. are sensitizing us to an impor-
tant methodological issue to adequately and reproducibly
estimate glycosaminoglycan distribution, the selection of
BMI as the measure to correct the bias appears ill-advised.
Body composition, speciﬁcally muscle mass, could be read-
ily estimated using bioelectrical impedance, or alternatively
from dual X-ray densitometry (DEXA) measurement of total
body. The former has the advantage in that it is theoretically
based on total body water, is not limited by the ability of
a densitometry table to hold a person with a weight in ex-
cess of 260 pounds, is easily acquired, and is not costly
to acquire relative to DEXA. We urge these investigators
to be as thoughtful in the selection of a body composition
measure for adjustment as they are in interpreting the gado-
linium-enhanced magnetic resonance imaging (MRI) data.
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